Description
The Defense Health Agency Contracting Activity (DHACA) intends to award a sole-source supply contract for Boston Scientific Corp. Y-90 glass Theraspheres to support the operational requirements of the Tripler Army Medical Center Department of Radiology. The contract will be for a base year and four option years. The Y-90 TheraSpheres are used in a targeted radiation therapy to treat hepatocellular carcinoma (HCC), a type of liver cancer.
* The contract is for a firm-fixed-price 5-year blanket purchase agreement.
* The contract will be awarded to Boston Scientific Corp., the sole distributor and commercial license holder of TheraSphere Y-90 Glass Microspheres in the United States.
* The delivery period is from 1 October 2026 to 30 September 2031.
* The delivery location is the Tripler Army Medical Center Department of Radiology in Honolulu, HI.
* Interested sources must submit a capability statement, including management, technical, and cost data, by the closing date of Thursday, August 13, 2026.